La/Al-SBA-15催化剂的制备及催化合成棕榈酸甲酯

以Al-SBA-15为载体,浸渍法制备La/Al-SBA-15改性介孔分子筛催化剂。通过红外光谱分析、X射线多晶衍射、N2吸附-脱附、扫描电子显微镜和透射电子显微镜等分析方法对催化剂进行表征。X射线多晶衍射表明,La/Al-SBA-15催化剂具有典型的一维六方介孔结构;红外光谱中显示出La—O键590 cm-1特征峰,表明La元素通过键合进入分子筛;N2吸附-脱附分析表明,La/Al-SBA-15催化剂的孔道分布均匀,平均孔径为2.15 nm。以La/Al-SBA-15催化剂合成棕榈酸甲酯,在n(棕榈酸)∶n(甲醇)=1∶20、催化剂用量为0.250 g(即为棕榈酸质量的5%)和反应时间330 min条件下,棕榈酸甲酯酯化率达79.48%。     

Effects of primer and annealing treatments on the shear strength between anodized Ti6Al4V and epoxy

The effects of primer and annealing treatments on the shear strength between anodized Ti6Al4V and epoxy were investigated. Primer coating improved the shear strength between anodized Ti alloy and epoxy by up to 81.3% using concurrent curing compared with that of control specimens. After annealing of anodized Ti alloy and applying primer, the shear strength of the specimen was further increased by 6.4% due to the formation of stable TiO₂ transferred from TiO in the anodization process. SEM analysis revealed the specimen without primer and annealing treatments showed adhesive failure between epoxy–alloy interface and discontinuous cohesive failure of epoxy. Primer coating initiated a new interfacial failure mode between the oxide layer and alloy due to the improved bonding strength between epoxy and oxide layer. In addition, annealing and primer treatments generated large tracts of epoxy continuous cohesive failure, showing good agreement with its higher shear strength and work of fracture.     

Shear testing of thick adhesive layers using the ENF-specimen

An existing experimental method to determine cohesive laws for adhesive layers loaded in shear is further developed. The method is based on differentiation of the energy release rate (ERR) with respect to the adhesive shear deformation at the crack tip. The test geometry used is an ENF-specimen for which the adherends are assumed to deform linearly elastic. The original method is expanded to account for situations where the thickness of the adhesive layer is not negligible as compared to the adherend thickness. To this end, a novel mathematical expression for the energy release rate (ERR) is derived. No assumptions on the form of the cohesive law are made; it is implicitly included in the derivation. The expression for the ERR contains the applied load and the shear deformation of the adhesive layer at the initial position of the crack tip, in addition to geometrical properties and the elastic modulus of the adherend material. Numerical simulations are performed to verify the accuracy of the mathematical expression for the ERR. Preliminary results from experiments performed on an epoxy adhesive are presented. The cohesive law of the adhesive layer is extracted by using a blunted crack tip. Verifying simulations confirm that the local pre-fracture behavior is accurately captured.     

Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation

Chronic hepatitis B virus (HBV) infection is a major global health problem with an estimated 400 million HBV carriers worldwide. In the natural history of chronic hepatitis B (CHB), spontaneous acute exacerbation (AE) is not uncommon, with a cumulative incidence of 10%–30% every year. While exacerbations can be mild, some patients may develop hepatic decompensation and even die. The underlying pathogenesis is possibly related to the activation of cytotoxic T lymphocyte-mediated immune response against HBV. An upsurge of serum HBV DNA usually precedes the rise of alanine aminotransferase (ALT) and bilirubin. Whether antiviral treatment can benefit CHB with severe AE remains controversial, but early nucleos(t)ide analogues treatment seemed to be associated with an improved outcome. There has been no randomized study that compared the effects of different nucleos(t)ide analogues (NA) in the setting of CHB with severe AE. However, potent NAs with good resistance profiles are recommended. In this review, we summarized current knowledge regarding the natural history, pathogenetic mechanisms, and therapeutic options of CHB with severe AE.     

Human Anti-Oxidation Protein A1M—A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy (PRRT) has been in clinical use for 15 years to treat metastatic neuroendocrine tumors. PRRT is limited by reabsorption and retention of the administered radiolabeled somatostatin analogues in the proximal tubule. Consequently, it is essential to develop and employ methods to protect the kidneys during PRRT. Today, infusion of positively charged amino acids is the standard method of kidney protection. Other methods, such as administration of amifostine, are still under evaluation and show promising results. α₁-microglobulin (A1M) is a reductase and radical scavenging protein ubiquitously present in plasma and extravascular tissue. Human A1M has antioxidation properties and has been shown to prevent radiation-induced in vitro cell damage and protect non-irradiated surrounding cells. It has recently been shown in mice that exogenously infused A1M and the somatostatin analogue octreotide are co-localized in proximal tubules of the kidney after intravenous infusion. In this review we describe the current situation of kidney protection during PRRT, discuss the necessity and implications of more precise dosimetry and present A1M as a new, potential candidate for renal protection during PRRT and related targeted radionuclide therapies.     

Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence

Hepatitis B often progresses to decompensated liver cirrhosis requiring orthotopic liver transplantation (OLT). Although newer nucleos(t)ide analogues result in >90% viral and hepatitis activity control, severely decompensated patients still need OLT because of drug-resistant virus, acute exacerbation, or hepatocellular carcinoma. Acute hepatitis B is also an indication for OLT, because it can progress to fatal acute liver failure. After OLT, the hepatitis B recurrence rate is >80% without prevention, while >90% of transplant recipients are clinically controlled with combined hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogue treatment. However, long-term HBIG administration is associated with several unresolved issues, including limited availability and extremely high cost; therefore, several treatment protocols with low-dose HBIG, combined with nucleos(t)ide analogues, have been investigated. Another approach is to induce self-producing anti-hepatitis B virus (HBV) antibodies using an HBV envelope (HBs) antigen vaccine. Patients who are not HBV carriers, such as those with acutely infected liver failure, are good candidates for vaccination. For chronic HBV carrier liver cirrhosis patients, a successful vaccine response can only be achieved in selected patients, such as those treated with experimentally reduced immunosuppression protocols. The present protocol for post-OLT HBV control and the future prospects of newer treatment strategies are reviewed.     

IgG and IgA with Potential Microbial-Binding Activity Are Expressed by Normal Human Skin Epidermal Cells

The innate immune system of the skin is thought to depend largely on a multi-layered mechanical barrier supplemented by epidermis-derived antimicrobial peptides. To date, there are no reports of antimicrobial antibody secretion by the epidermis. In this study, we report the expression of functional immunoglobulin G (IgG) and immunoglobulin A (IgA), previously thought to be only produced by B cells, in normal human epidermal cells and the human keratinocyte line HaCaT. While B cells express a fully diverse Ig, epidermal cell-expressed IgG or IgA showed one or two conservative V_HDJ_H rearrangements in each individual. These unique VDJ rearrangements in epidermal cells were found neither in the B cell-derived Ig VDJ databases published by others nor in our positive controls. IgG and IgA from epidermal cells of the same individual had different VDJ rearrangement patterns. IgG was found primarily in prickle cells, and IgA was mainly detected in basal cells. Both epidermal cell-derived IgG and IgA showed potential antibody activity by binding pathogens like Staphylococcus aureus, the most common pathogenic skin bacteria, but the microbial-binding profile was different. Our data indicates that normal human epidermal cells spontaneously express IgG and IgA, and we speculate that these Igs participate in skin innate immunity.     

Chromium substituted copper ferrites via gluconate precursor route

CuFe_2−xCr_xO₄ spinel (0≤x≤2) powders were synthesized by a soft chemistry method—the gluconate multimetallic complex precursor route. The complex precursors were characterized by elemental chemical analysis, infrared (IR) and ultraviolet–visible (UV–vis) spectroscopy, thermal analysis and Mössbauer spectroscopy. The oxide powders were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), IR, Raman and Mössbauer spectroscopy. It was shown that the structure, morphology and magnetic properties of the obtained spinel powders depend on the concentration of Cr³⁺ ion. The XRD of the chromium substituted copper ferrite powders calcined at 700 °C/1 h indicated the formation of a cubic spinel type structure for x=0.5, 1.0 and a tetragonal structure for x=0, 0.2, 2. The crystallite size ranged from 19 nm to 39 nm. The Mössbauer spectroscopy revealed the site occupancy of iron ions, relative abundance and internal hyperfine magnetic fields in both tetrahedral and cubic CuFe_2−xCr_xO₄ spinels.     

Synthesis and characterization of MgAl2O4 micro-rods by a molten salt method

Large amounts of MgAl₂O₄ micro-rods were successfully synthesized using the molten-salt technology. The effect of KCl contents on the formation of MgAl₂O₄ micro-rods was investigated. The structure and morphology of MgAl₂O₄ were investigated by means of powder X-ray diffraction, field emission scanning electron microscopy, and transmission electron microscopy, respectively. The experimental results showed that the contents of KCl significantly influenced the formation of MgAl₂O₄ micro-rods. MgAl₂O₄ micro-rods could be prepared at 1150 °C with a weight ratio of 100:1 between the salt and the starting materials. The formation of MgAl₂O₄ micro-rods could be suggested to be due to the inhomogeneous nucleation and orientated growth perpendicularly to the surfaces of Al₂O₃ grains. An impedance-type humidity sensor was finally fabricated based on the as-prepared MgAl₂O₄ micro-rods. According to tests of the humidity performance, MgAl₂O₄ micro-rods might be suitable for high-performance humidity sensors.